[Use of sulfamethoxypyrazine in persons with an erythrocytic glucose-6-phosphate deficiency].
D000293:Adolescent; D000328:Adult; D001663:Bilirubin / Q000032:analysis; D001772:Blood Cell Count; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects*; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000628:therapy*; D005978:Glutathione / Q000032:analysis; D006366:Heinz Bodies; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008297:Male; D008706:Methemoglobin / Q000032:analysis; D012156:Reticulocytes; D013268:Stimulation, Chemical; D013449:Sulfonamides / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*
D006454:Hemoglobins; D013449:Sulfonamides; D008706:Methemoglobin; D005978:Glutathione; D001663:Bilirubin
Zur Anwendung von Sulfamethoxypyrazin bei Personen mit Mangel der Glucose-6-Phosphat-Dehydrogenase der Erythrocyten.